Eltrombopag Olamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 22 USDMF, 4 JDMF, 7 EU WC, 4 KDMF, 16 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

186 FDF Dossiers, 33 FDA Orange Book, 105 Europe, 4 Canada, 16 Australia, 2 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 12.5MG ACID, TABLET;ORAL - EQ 25MG ACID, TABLET;ORAL - EQ 50MG ACID, TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 7 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 14 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 22 Direct Compression, 22 Controlled & Modified Release, 20 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 18 Solubilizers, 16 Granulation, 15 Taste Masking, 15 Chewable & Orodispersible Aids, 14 Parenteral, 12 Lubricants & Glidants, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Rheology Modifiers, 8 Topical, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 11 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents, 13 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP

2 USP

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22291 / DOSAGE - TABLET;ORAL - EQ 50MG ACID

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ELTROMBOPAG OLAMINE(UNII: 4U07F515LG) (ELTROMBOPAG - UNII:S56D65XJ9G)	ELTROMBOPAG	25mg \| 75mg \| 12.5mg \| 100mg \| 25mg \| 50mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C YELLOW NO. 6(H77VEI93A8)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYSORBATE 80(6OZP39ZG8H)
POLYVINYL ALCOHOL(532B59J990)
POVIDONES(FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
SUCRALOSE(96K6UQ3ZD4)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
XANTHAN GUM(TTV12P4NEE)

Setid 616224ff A925 4b38 9ca2 00fbf669380f Applno 22291 Form Tablet Oral Dosage Eq 50mg Acid - Drug Product Composition: Eltrombopag Olamine